Free Trial

Mesa Laboratories (MLAB) SEC Filings & 10K Form

Mesa Laboratories logo
$69.17 +4.02 (+6.17%)
Closing price 04:00 PM Eastern
Extended Trading
$69.14 -0.03 (-0.04%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Mesa Laboratories SEC Filings

DateFilerForm TypeView
08/25/2025
2:13 PM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2025
1:37 PM
Ladiwala Shiraz Shabanali (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025
1:20 PM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025
12:34 PM
Alltoft Jennifer Sadie (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025
12:45 PM
Capone Mark Christopher (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025
12:54 PM
Mesa Laboratories (Issuer)
Tripeny R Tony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025
1:02 PM
Hall Shannon (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025
1:03 PM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2025
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2025
7:01 AM
Mesa Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2025
11:06 AM
BlackRock, Inc. (Filed by)
Mesa Laboratories (Subject)
Form SCHEDULE 13G/A
07/11/2025
7:00 AM
Mesa Laboratories (Filer)
Form DEF 14A
06/25/2025
8:14 AM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
8:05 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
9:12 AM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
4:39 PM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
4:31 PM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
4:22 PM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
11:04 AM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
11:12 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
11:18 AM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
10:27 AM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
10:13 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
9:59 AM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
2:40 PM
Mesa Laboratories (Subject)
Sakys John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2025
2:47 PM
Mesa Laboratories (Subject)
Owens Gary M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2025
2:49 PM
Archbold Brian David (Reporting)
Mesa Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2025
9:23 AM
Archbold Brian David (Reporting)
Mesa Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
9:30 AM
Mesa Laboratories (Issuer)
Sakys John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
9:16 AM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
2:00 PM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
7:01 AM
Mesa Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/30/2025
10:44 AM
Mesa Laboratories (Subject)
ROYCE & ASSOCIATES LP (Filed by)
Form SCHEDULE 13G/A
03/24/2025
12:38 PM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:12 PM
Mesa Laboratories (Subject)
Owens Gary M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
7:00 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
7:00 AM
Mesa Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/28/2025
10:55 AM
Mesa Laboratories (Subject)
ROYCE & ASSOCIATES LP (Filed by)
Form SCHEDULE 13G/A
01/10/2025
10:55 AM
Conestoga Capital Advisors, LLC (Filed by)
Mesa Laboratories (Subject)
Form SCHEDULE 13G/A
11/25/2024
10:40 AM
Mesa Laboratories (Issuer)
Sullivan John James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
7:03 AM
Mesa Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
7:05 AM
Mesa Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
7:18 PM
Mesa Laboratories (Issuer)
Owens Gary M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
2:47 PM
Mesa Laboratories (Subject)
Owens Gary M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/28/2024
2:12 PM
Mesa Laboratories (Subject)
Owens Gary M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
12:29 PM
Mesa Laboratories (Subject)
ROYCE & ASSOCIATES LP (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MLAB) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners